Article by Shannon Palus published online at Slate.com December 11, 2020.
The Pfizer-BioNtech vaccine was just granted the first emergency use authorization (EUA) in the U.S., allowing the company to start shipping the first couple of million doses. A second vaccine candidate developed by Moderna will be reviewed by the special FDA advisory panel on December 17th. We have questions. Here is a nice summary that checks off most of the right boxes from Slate. Stay tuned as further details emerge and send me any specific questions you might have.
Today’s bite-sized, handpicked selection of important news, information or science for all who want to know where this epidemic is going and what we should do.